Lonza is poised for growth amid margin recovery, onshoring opportunities, and strong profit projections. Read more on LZAGY ...

For Series A, some differences emerge. The median size for Utilities, Food & Beverage, Household Goods and Agriculture was $3 ...

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...

FM:Systems today announced the integration of its flagship workplace management solution, FMS:Workplace with Johnson Controls Metasys building automation system. The integration allows for rapid ...

CDMO, has appointed Dr James Miskin as Non-Executive Director. James brings extensive experience in the cell and gene therapy sector, following a 23-year tenure at Oxford Biomedica. He oversaw ...

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, ...

This lease extension gives Northstar the option to retrofit the Empower Delta Facility, formerly home to its pilot facility, into a commercial-scale operation.

The equity financing is at a 10% premium to the market share price1 ZÜRICH, SWITZERLAND / ACCESS Newswire / March 31, 2025 / NLS Pharmaceutics Ltd.(NASDAQ:NLSP) ("NLS" or the "Company"), a Swiss clini ...

European markets are expected to open lower Monday as global markets await U.S. President Donald Trump’s previously announced ...

Guo Guangchang, Chairman of Fosun International Limited (HKEX: 0656), issued a letter to its shareholders on 30 March, outlining the Company's strategic direction, accomplishments, and future plans.

After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much ...

Despite a challenging 2024, VirTra saw a 37% increase in Q4 bookings and international growth, particularly in Latin America ...